# Temporal lobe epilepsy is associated with neuroinflammation, extracellular matrix remodeling, and synaptic protein alterations

**Authors:** Sophia Auer, Lucas Hoffmann, Martin Schicht, Ingmar Blümcke, Friedrich Paulsen

PMC · DOI: 10.3389/fnmol.2026.1728666 · Frontiers in Molecular Neuroscience · 2026-02-20

## TL;DR

This study finds that temporal lobe epilepsy involves inflammation and changes in brain tissue structure, particularly in the hippocampus, which may lead to seizures.

## Contribution

The study identifies region-specific molecular changes in the hippocampus linked to neuroinflammation and synaptic dysfunction in temporal lobe epilepsy.

## Key findings

- Hippocampal TLE tissue shows upregulation of proteins related to inflammation and extracellular matrix remodeling.
- Synaptic proteins like glutamate and GABA receptors are downregulated in the hippocampus but preserved or increased in neocortical and white matter regions.
- The findings suggest that hippocampal inflammation contributes to epileptogenesis, while other brain regions may compensate.

## Abstract

Temporal lobe epilepsy is the most prevalent form of drug-resistant focal epilepsy and is frequently associated with neuronal cell loss and astrogliosis in the hippocampus, i.e. hippocampal sclerosis (HS).

In this study, we performed mass spectrometry-based proteomic profiling of microdissected hippocampal, neocortical, and white matter tissue obtained from TLE patients and respective control samples.

In hippocampal TLE tissue, we observed significant upregulation of proteins involved in complement system activation, extracellular matrix (ECM) organization, and astrocyte reactivity, indicative of active inflammatory remodeling within the sclerotic hippocampus. Conversely, synaptic proteins, including glutamate and gamma-aminobutyric acid (GABA) receptors, along with other regulators of synaptic structure and function, were markedly downregulated. Interestingly, in neocortical and white matter regions from the same TLE patients, immune- and ECM-related proteins were downregulated or unchanged, whereas synaptic proteins were preserved or upregulated.

These region-specific molecular signatures suggest that inflammatory-driven ECM remodeling is spatially restricted to the epileptogenic hippocampus, where it may contribute to synaptic destabilization and network dysfunction. Together, our findings support the hypothesis that inflammatory ECM remodeling in the hippocampus plays a central role in epileptogenesis in TLE. In contrast, the neocortical and white matter regions may undergo compensatory adaptions. The convergence of immune and ECM-related alterations on synaptic structures highlights a potential pathophysiological axis in epilepsy and points to novel molecular targets for therapeutic intervention.

## Linked entities

- **Proteins:** LOC112683356 (glutamate [NMDA] receptor subunit 1-like)
- **Diseases:** temporal lobe epilepsy (MONDO:0005115)

## Full-text entities

- **Genes:** S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, HAPLN4 (hyaluronan and proteoglycan link protein 4) [NCBI Gene 404037] {aka BRAL2}, CPLX3 (complexin 3) [NCBI Gene 594855] {aka CPX-III, CPXIII, Nbla11589}, ITGA2B (integrin subunit alpha 2b) [NCBI Gene 3674] {aka BDPLT16, BDPLT2, CD41, CD41B, FMAIT2, GP2B}, FCGR2A (Fc gamma receptor IIa) [NCBI Gene 2212] {aka CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1}, HRG (histidine rich glycoprotein) [NCBI Gene 3273] {aka HPRG, HRGP, THPH11}, GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1) [NCBI Gene 2554] {aka DEE19, ECA4, EIEE19, EJM, EJM5}, STXBP5 (syntaxin binding protein 5) [NCBI Gene 134957] {aka LGL3, LLGL3, Nbla04300}, NDUFS7 (NADH:ubiquinone oxidoreductase core subunit S7) [NCBI Gene 374291] {aka CI-20, CI-20KD, MC1DN3, MY017, PSST}, DLG4 (discs large MAGUK scaffold protein 4) [NCBI Gene 1742] {aka MRD62, PSD95, SAP-90, SAP90}, GPRIN3 (GPRIN family member 3) [NCBI Gene 285513] {aka GRIN3}, PPBP (pro-platelet basic protein) [NCBI Gene 5473] {aka B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7}, PGLYRP2 (peptidoglycan recognition protein 2) [NCBI Gene 114770] {aka HMFT0141, PGLYRPL, PGRP-L, PGRPL, TAGL-like, tagL}, GRIA2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 2891] {aka GLUR2, GLURB, GluA2, GluR-K2, HBGR2, NEDLIB}, CACNA1B (calcium voltage-gated channel subunit alpha1 B) [NCBI Gene 774] {aka BIII, CACNL1A5, CACNN, Cav2.2, DYT23, NEDNEH}, DLGAP3 (DLG associated protein 3) [NCBI Gene 58512] {aka DAP3, SAPAP3, SPAPA3}, S100A6 (S100 calcium binding protein A6) [NCBI Gene 6277] {aka 2A9, 5B10, CABP, CACY, PRA, S10A6}, CTSG (cathepsin G) [NCBI Gene 1511] {aka CATG, CG}, LAMB2 (laminin subunit beta 2) [NCBI Gene 3913] {aka LAMS, NPHS5, PIERS}, CFH (complement factor H) [NCBI Gene 3075] {aka AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH}, GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904] {aka DEE27, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B}, SYT6 (synaptotagmin 6) [NCBI Gene 148281] {aka sytVI}, SYNGAP1 (synaptic Ras GTPase activating protein 1) [NCBI Gene 8831] {aka MRD5, RASA5, SYNGAP}, LRRTM2 (leucine rich repeat transmembrane neuronal 2) [NCBI Gene 26045], GRIK3 (glutamate ionotropic receptor kainate type subunit 3) [NCBI Gene 2899] {aka EAA5, GLR7, GLUR7, GluK3, GluR7a}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, SHANK3 (SH3 and multiple ankyrin repeat domains 3) [NCBI Gene 85358] {aka DEL22q13.3, PROSAP2, PSAP2, SCZD15, SPANK-2}, GRIA1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 2890] {aka GLUH1, GLUR1, GLURA, GluA1, HBGR1, MRD67}, ITGA7 (integrin subunit alpha 7) [NCBI Gene 3679], LINGO1 (leucine rich repeat and Ig domain containing 1) [NCBI Gene 84894] {aka LERN1, LRRN6A, MRT64, UNQ201}, KCNIP4 (potassium voltage-gated channel interacting protein 4) [NCBI Gene 80333] {aka CALP, KCHIP4}, SYT17 (synaptotagmin 17) [NCBI Gene 51760] {aka Syt-17, sytXVII}, LAMA2 (laminin subunit alpha 2) [NCBI Gene 3908] {aka LAMM, MDC1A}, NPTX2 (neuronal pentraxin 2) [NCBI Gene 4885] {aka NARP, NP-II, NP2}, SYNPR (synaptoporin) [NCBI Gene 132204] {aka SPO}, C8B (complement C8 beta chain) [NCBI Gene 732] {aka C82}, KCNAB1 (potassium voltage-gated channel subfamily A regulatory beta subunit 1) [NCBI Gene 7881] {aka AKR6A3, KCNA1B, KV-BETA-1, Kvb1.3, hKvBeta3, hKvb3}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, SEMA4A (semaphorin 4A) [NCBI Gene 64218] {aka CORD10, RP35, SEMAB, SEMB}, CFI (complement factor I) [NCBI Gene 3426] {aka AHUS3, ARMD13, C3BINA, C3b-INA, FI, IF}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, STXBP5L (syntaxin binding protein 5L) [NCBI Gene 9515] {aka LLGL4}, C4B (complement C4B (Chido/Rodgers blood group)) [NCBI Gene 721] {aka C4B1, C4B12, C4B3, C4B5, C4BD, C4F}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, GRM2 (glutamate metabotropic receptor 2) [NCBI Gene 2912] {aka GLUR2, GPRC1B, MGLUR2, mGlu2}, SHISA7 (shisa family member 7) [NCBI Gene 729956] {aka CKAMP59}, TNC (tenascin C) [NCBI Gene 3371] {aka 150-225, DFNA56, GMEM, GP, HXB, JI}, ACAN (aggrecan) [NCBI Gene 176] {aka AGC1, AGCAN, CSPG1, CSPGCP, MSK16, SEDK}, THBS1 (thrombospondin 1) [NCBI Gene 7057] {aka THBS, THBS-1, TSP, TSP-1, TSP1}, DLG2 (discs large MAGUK scaffold protein 2) [NCBI Gene 1740] {aka PPP1R58, PSD-93, PSD93, chapsyn-110}, HOMER2 (homer scaffold protein 2) [NCBI Gene 9455] {aka ACPD, CPD, DFNA68, HOMER-2, VESL-2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, SYT5 (synaptotagmin 5) [NCBI Gene 6861], AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, GABARAP (GABA type A receptor-associated protein) [NCBI Gene 11337] {aka ATG8A, GABARAP-a, MM46}, GRM5 (glutamate metabotropic receptor 5) [NCBI Gene 2915] {aka GPRC1E, MGLUR5, PPP1R86, mGlu5}, KCND2 (potassium voltage-gated channel subfamily D member 2) [NCBI Gene 3751] {aka KV4.2, RK5}, DLGAP1 (DLG associated protein 1) [NCBI Gene 9229] {aka DAP-1, DAP-1-ALPHA, DAP-1-BETA, DAP1, DLGAP1A, DLGAP1B}
- **Diseases:** SE (MESH:D013226), synaptic (MESH:D012183), seizure (MESH:D012640), neurological disorders (MESH:D009461), mTLE (MESH:C566903), WM (MESH:D056784), Focal epilepsies (MESH:D004828), neuronal (MESH:D009410), atrophy (MESH:D001284), neuroinflammation (MESH:D000090862), schizophrenia (MESH:D012559), central nervous system (CNS) disorders (MESH:D002493), Alzheimer's disease (MESH:D000544), TLE (MESH:D004833), Mitochondrial dysfunction (MESH:D028361), Inflammatory (MESH:D007249), neurological or neuropathological disease (MESH:D019636), HS (MESH:D000092223), astrogliosis (MESH:D005911), Epilepsy (MESH:D004827)
- **Chemicals:** hyaluronan (MESH:D006820), calcium (MESH:D002118), tungsten carbide (MESH:C002802), GABA (MESH:D005680), peptide (MESH:D010455), water (MESH:D014867), TFA (MESH:D014269), Acetonitrile (MESH:C032159), Ammonium Bicarbonate (MESH:C027043), RPM (MESH:D020123), C (MESH:D002244), TCEP (MESH:C080938), formic acid (MESH:C030544), HEPES (MESH:D006531), Cysteine carbamidomethyl (-), CAA (MESH:C013874), methanol (MESH:D000432)
- **Species:** Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963051/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963051/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963051/full.md

---
Source: https://tomesphere.com/paper/PMC12963051